Target Health and LifeOnKey Receive BIRD Foundation Award to Integrate the EMR with the EDC Clinical Trial Database

Target Health and LifeOnKey Receive BIRD Foundation Award to Integrate the EMR with the EDC Clinical Trial Database

PHILADELPHIA --3/11/13

Target Health Inc., and LifeOnKey Inc., announced at CLINTECH 2013 that they are recipients of a $900,000, 2-year award from BIRD Foundation. The award, entitled, "EMR/EDC HUB - An Electronic Bridge between Medicine and Science," will integrate the EMR with electronic data capture (EDC) systems for clinical trials.

The Israel-United States Binational Industrial Research and Development (BIRD) Foundation, established in 1977, receives joint funding from the American and Israeli governments to back collaborative research and development projects involving one American and one Israeli company.

The integration of the LifeOnKey EHR with the Target e*CRF EDC system, and the new applications and solutions to be developed, assures compliance with FDA's rules and regulations that 1) the clinical research investigator maintain original source records; 2) source data can only be modified with the approval of the Investigator; 3) the pharmaceutical company sponsor will not have exclusive control of source data; and 4) clinical trial data and registries used as a tool for post marketing surveillance, will be maintained in one platform.
Business Wire -

"We are very enthusiastic about building a comprehensive solution for the integration of clinical trial software and EMRs for the industry," comments Target Health's President Dr. Jules Mitchel. "With over 20 years of clinical trial and clinical trial information systems developed and implemented at Target Health, coupled with the state-of-the-art Health Management Platform offered by LifeOnKey, this partnership is the first of its kind in the field of Clinical Trials." Dr. Mitchel added that "the time has come for the pharmaceutical and device industries to embrace technology solutions to replace currently used paper-centric processes."

"LifeOnKey is joining forces with Target Health to bring to the market the first integrated system to enable clinical research to be part of the revolution in health information systems, and that LifeOnKey's vast experience and know-how in health information systems compliments the outstanding product development expertise of Target Health," explains Dr. Linda Harnevo, CEO of LifeOnKey. Dr. Harnevo added that "It is clear that interfacing EMRs, using the LifeOnKey EMRHub, with both clinical trial database systems such as EDC as well as post-marketing patient registries will become increasingly important in the years to come."

About Target Health Inc.

Target Health Inc., established in 1999, Target Health Inc. is a privately held, New York City-based, full service e*CRO dedicated to all aspects of Drug and Device Development including: Strategic Planning, Regulatory Affairs, Clinical Research, Data Management, Biostatistics, Internet-Based Clinical Trials (EDC, electronic data capture), Medical Writing and Software for the Paperless Clinical Trial.

About LifeOnKey, Inc.

LifeOnKey is an innovative provider of a health platform and solutions for connected healthcare. It develops and markets the eHealthStudio™ a proven syndication platform for patient-centric business processes and health applications (web and mobile). These medico-business processes and Apps perform independently, or can be integrated into legacy systems to generate innovative applications across the health landscape and leverage its information assets, driving improvements in the quality, and efficiency of patient care. Among other properties, the Studio facilitates the aggregation, dissemination and sharing of medical data between physicians, consumers, patients, hospitals, labs, pharmacies, payers, Pharma companies, marketers, and researchers – data to be used within each of the Apps. Applications meet the meaningful use standards. LOK currently has contracts worldwide as well as 2 million files in its network.

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.